258 related articles for article (PubMed ID: 5300097)
1. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
[No Abstract] [Full Text] [Related]
2. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
[No Abstract] [Full Text] [Related]
3. [Advances and principles in tuberculostatic therapy].
Bethge H
Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
[No Abstract] [Full Text] [Related]
4. [Actual tuberculosis therapy. An attempt to simplify and to determine a schedule of tuberculosis chemotherapy].
Virchow C
Munch Med Wochenschr; 1969 Aug; 111(35):1717-22. PubMed ID: 4309162
[No Abstract] [Full Text] [Related]
5. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
[No Abstract] [Full Text] [Related]
6. [Drug therapy of tuberculosis].
Jentgens H
Dtsch Med Wochenschr; 1974 Aug; 99(32):1627-30. PubMed ID: 4135677
[No Abstract] [Full Text] [Related]
7. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
Fegiz G
Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
[No Abstract] [Full Text] [Related]
8. [Chemotherapeutic studies on advanced tuberculosis in mice].
Grumbach F
Bibl Tuberc; 1965; 21():31-96. PubMed ID: 4301034
[No Abstract] [Full Text] [Related]
9. In vitro and in vivo studies to assess the suitability of anti-tuberculous drugs for use in intermittent chemotherapy regimens.
Dickinson JM
Bull Int Union Tuberc; 1968 Dec; 41():309-15. PubMed ID: 4179554
[No Abstract] [Full Text] [Related]
10. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
Bernard E
Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
[No Abstract] [Full Text] [Related]
11. [New combinations of drugs for the treatment of drug-resistant tuberculosis].
Schmelev NA
Bull Int Union Tuberc; 1968 Dec; 41():192-3. PubMed ID: 5710248
[No Abstract] [Full Text] [Related]
12. [Drug therapy of urogenital tuberculosis].
König K
Urologe; 1970 Jan; 9(1):44. PubMed ID: 5461516
[No Abstract] [Full Text] [Related]
13. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
[No Abstract] [Full Text] [Related]
14. [Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice].
Matsumiya T; Freerksen E; Rosenfeld M
Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):30-4. PubMed ID: 4991617
[No Abstract] [Full Text] [Related]
15. Treatment of tuberculosis.
Bates JH
Adv Intern Med; 1975; 20():1-21. PubMed ID: 46687
[No Abstract] [Full Text] [Related]
16. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
[No Abstract] [Full Text] [Related]
17. Problems of treatment of drug resistance in the developing countries.
Fox W
Tubercle; 1969 Mar; 50():Suppl:55-65. PubMed ID: 5402546
[No Abstract] [Full Text] [Related]
18. [Certain aspects of new combinations of drugs for the treatment of drug-resistant tuberculosis].
Jancík E; Novák M; Jancíková M; Tousek J; Krátký J; Feitová S; Zelenka M
Bull Int Union Tuberc; 1968 Dec; 41():188-91. PubMed ID: 5710247
[No Abstract] [Full Text] [Related]
19. The treatment of infection due to "atypical" mycobacteria.
Johnston RN
Tubercle; 1969 Mar; 50():Suppl:88-92. PubMed ID: 4319136
[No Abstract] [Full Text] [Related]
20. [Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
Suzuki T
Kekkaku; 1971 May; 46(5):153-64. PubMed ID: 4325363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
